Quantification of Insulin Secretion in Relation to Insulin Sensitivity in Nondiabetic Postmenopausal Women
Abstract
To evaluate mechanisms underlying the close association between insulin secretion and insulin sensitivity, insulin sensitivity was evaluated by the euglycemic-hyperinsulinemic clamp technique (M/Iclamp) and insulin secretion was determined from the 75-g oral glucose tolerance test (OGTT) and from the glucose-dependent arginine-stimulation test in 81 nondiabetic postmenopausal women, all aged 61 years. M/Iclamp was normally distributed with mean ± SD of 69.9 ± 30.5 nmol glucose · kg−1 · min−1/pmol insulin · l−1. It was found that the several different measures of insulin secretion from the OGTT and the glucose-dependent arginine-stimulation test were all inversely related to M/Iclamp. However, measures determining the direct insulin responses were more markedly potentiated by low M/Iclamp than were measures determining glucose potentiation of insulin secretion. Moreover, the product of M/Iclamp times measures of insulin secretion (disposition index [DI]) was inversely related to the 2-h glucose value. Finally, surrogate insulin sensitivity measures quantified from OGTT and the glucose-dependent arginine-stimulation test only weakly correlated to M/Iclamp (R2 ≈ 0.25). Thus, 1) insulin secretion is adaptively increased when insulin sensitivity is low in nondiabetic postmenopausal women; 2) β-cell exocytotic ability shows more efficient adaptation than β-cell glucose recognition to low insulin sensitivity; 3) impaired β-cell adaptation (i.e., low DI) is associated with higher 2-h glucose values during OGTT, although other regulatory mechanisms also exist; and 4) indirect surrogate measures of insulin sensitivity only weakly correlate to insulin sensitivity as determined by the euglycemic-hyperinsulinemic clamp.
Footnotes
-
Address correspondence and reprint requests to bo.ahren{at}med.lu.se.
Accepted for publication 26 June 2001.
AIR, arginine-induced insulin release; BG, blood glucose; DI, disposition index; HOMA, homeostasis model assessment; IGT, impaired glucose tolerance; IGratio, insulin-to-glucose ratio; insindex, insulinogenic index; IR, insulin response; ISI, insulin sensitivity index; M/Iclamp, insulin sensitivity by euglycemic-hyperinsulinemic clamp technique; OGTT, oral glucose tolerance test; WHO, World Health Organization.
The symposium and the publication of this article were made possible by an unrestricted educational grant from Servier, Paris.











